Patent details

Basic Information

Publication number:

EP1527063

PCT Application Number:

PCT/US/2003/024305

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037671294

PCT Publication Number:

WO/2004/013119

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

THE 9, 11-CYCLOENDOPEROXIDE PRO-DRUGS OF PROSTAGLANDIN ANALOGUES FOR TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA

French Title of Invention:

PROMEDICAMENTS RENFERMANT 9, 11-CYCLOENDOPEROXYDE DES ANALOGUES DE LA PROSTAGLANDINE DESTINES AU TRAITEMENT DE L'HYPERTENSION OCULAIRE ET DU GLAUCOME

German Title of Invention:

9,11-CYCLOENDOPEROXYD PRODRUGS VON PROSTAGLANDINANALOGEN FÜR DIE BEHANDLUNG VON OKULARER HYPERTENSION UND GLAUKOMA

SPC Number:

Dates

Filing date:

04/08/2003

Grant date:

26/07/2006

EP Publication Date:

26/07/2006

PCT Publication Date:

12/02/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/05/2005

EP B1 Publication Date:

26/07/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/08/2006

Expiration date:

04/08/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

04/08/2003

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, Irvine, California 92612, United States (US)

Inventor

1

Name:

YUAN Haiqing

Address:

United States (US)

2

Name:

YANG Wu

Address:

United States (US)

3

Name:

LING Kah-Hiing, John

Address:

United States (US)

4

Name:

NI Jinsong

Address:

United States (US)

5

Name:

TANG-LIU Diane, D., S.

Address:

United States (US)

Priority

Priority Number:

212437

Priority Date:

05/08/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 317/06;

Filing date	Document type	Number of pages